Does RAMIPRIL Cause Pulmonary fibrosis? 436 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 436 reports of Pulmonary fibrosis have been filed in association with RAMIPRIL (Ramipril). This represents 1.3% of all adverse event reports for RAMIPRIL.
436
Reports of Pulmonary fibrosis with RAMIPRIL
1.3%
of all RAMIPRIL reports
326
Deaths
319
Hospitalizations
How Dangerous Is Pulmonary fibrosis From RAMIPRIL?
Of the 436 reports, 326 (74.8%) resulted in death, 319 (73.2%) required hospitalization, and 369 (84.6%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMIPRIL. However, 436 reports have been filed with the FAERS database.
What Other Side Effects Does RAMIPRIL Cause?
Acute kidney injury (3,286)
Dyspnoea (2,537)
Dizziness (2,490)
Hypotension (2,417)
Fatigue (2,415)
Drug ineffective (2,412)
Nausea (2,219)
Vomiting (2,055)
Off label use (2,053)
Hypertension (2,046)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which RAMIPRIL Alternatives Have Lower Pulmonary fibrosis Risk?
RAMIPRIL vs RAMUCIRUMAB
RAMIPRIL vs RANEXA
RAMIPRIL vs RANIBIZUMAB
RAMIPRIL vs RANIMUSTINE
RAMIPRIL vs RANITIDINE